Keywords: therapy; HbA1c; carbohydrate counting; CSII; Continuous subcutaneous insulin infusion; HbA1c; Hemoglobin A1c; MDI; Multiple daily injections;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: diabetes; closed-loop; continuous glucose monitor; insulin pump; glucose; hyperglycemia; hypoglycemia; AID; Automated insulin delivery; AP; Artificial pancreas; BGCs; Blood glucose concentrations; CGM; Continuous glucose monitoring; CSII; Continuous subcu
Keywords: T1D; type 1 diabetes; BrazDiab1SG; Brazilian Type 1 Diabetes Study Group; DCCT; Diabetes Control and Complications Trial; EDIC; Epidemiology of Diabetes Interventions and Complications; ITRs; insulin therapeutic regimens; SMBG; self-monitoring of blood gl
Keywords: Irisin; CSII; T2DM; Lipid profiles; HbA1c;
Keywords: CSII; continuous subcutaneous insulin infusion; DM1; diabetes mellitus type 1; HbA1c; glycated haemoglobin; ICT; intensified conventional insulin therapy; ISA; insulin dose self-adjustment; Self-adjustment of insulin dose; Diabetes mellitus type 1;
Keywords: T1DM; type 1 diabetes; CSII; continuous subcutaneous insulin infusion; HbA1c; glycated haemoglobin A1c; SGA; small-for-gestational age; MDI; multiple daily injections of insulin; RCT; randomized control trials; PIH; pregnancy-induced hypertension; SD; sta
Keywords: CGM; Continuous glucose monitoring; CSII; Continuous insulin infusion; DKA; Diabetic ketoacidosis; HbA1c; Hemoglobin A1c; JDRF; Juvenile Diabetes Research Foundation; MDI; Multiple daily injection; MPC; Model predictive control; PID; Proportional-integral
Keywords: adolescents; youth; dietary adherence; BMI; Body mass index; CDC; Centers for Disease Control and Prevention; CDDUX; Celiac disease-specific DUX; CSII; Continuous subcutaneous insulin infusion; GFD; Gluten-free diet; GFD+; Gluten-free diet adherence; GF
Keywords: BMI; body mass index; CSII; continuous subcutaneous insulin infusion; FIT; Forum for Injection Technique; FITTER; Forum for Injection Technique and Therapy: Expert Recommendations; GLP-1; glucagon-like peptide-1; HCP; health care professional; IM; intramu
Keywords: CSII; diabetes; travel; diabète; voyage; PSCCI;
Keywords: ANCOVA; analysis of covariance; CSII; continuous subcutaneous insulin infusion; HbA1c; glycated hemoglobin; MDI; multiple daily injections; MRI; magnetic resonance imaging; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; PDF
Keywords: CGM; continuous glucose monitoring; continuous subcutaneous insulin infusions; CSII; insulin pumps; insulin therapy; self-monitoring of blood glucose; SMBG;
Keywords: CSII; continuous subcutaneous insulin infusion; HbA1c; haemoglobin A1c; HFS; Hypoglycaemia Fear Survey; HypoA-Q; Hypoglycaemia Awareness Questionnaire; IAH; impaired awareness of hypoglycaemia; PAID; Problem Areas In Diabetes; SH; severe hypoglycaemia; Ty
Keywords: CGM; continuous glucose monitoring; AP; artificial pancreas; CHO; carbohydrates; CSII; continuous subcutaneous insulin infusion; MARD; mean absolute relative deviation; SMGB; self-monitored blood glucose; Interval model; Identification; Type 1 diabetes; V
Trajectories of Body Mass Index from Childhood to Young Adulthood among Patients with Type 1 Diabetes-A Longitudinal Group-Based Modeling Approach Based on the DPV Registry
Keywords: BMI z score; developmental curves; diabetes; puberty; latent class growth modeling; ADHD; Attention-deficit hyperactivity disorder; BIC; Bayes information criterion; BMI; Body mass index; BMIz; BMI z score; CSII; Continuous subcutaneous insulin infusion;
Change in hemoglobin A1c one year following the 2014 American Diabetes Association guideline update
Keywords: HbA1c; Hemoglobin A1c; ADA; American Diabetes Association; ISPAD; International Society for Pediatric and Adolescent Diabetes; CGM; continuous glucose monitor; CSII; continuous subcutaneous insulin infusion; MDI; multiple daily injection; SSI; sliding-sca
Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A
Keywords: CSII; MDI; Type 1 diabetesISCI; MDI; Diabetes tipo 1
Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A
Keywords: CSII; MDI; Type 1 diabetesISCI; MDI; Diabetes tipo 1
Profiling intra-patient type I diabetes behaviors
Keywords: Type 1 diabetes; Continuous glucose monitoring; Insulin pumps; Time series prediction; Clustering; AUC180; the area under the curve above 180; AUC70; the area under the curve below 70; BG; blood glucose; BGV; the blood glucose variability; CGM; continuous
Characterization of metabolic responders on CSII treatment amongst children and adolescents in Denmark from 2007 to 2013
Keywords: CSII; Children and adolescents; Hypoglycemia; Boluses; Self monitored blood glucoses;
Pregnancy outcome and glycemic control in women with type 1 diabetes: A retrospective comparison between CSII and MDI treatment
Keywords: Abortion; CSII; HbA1c; MDI; Type 1 diabetes
Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy
Keywords: Insulin allergy; Tolerance induction; Children; CSII; Type 1 diabetesAllergie à l’insuline; Induction de tolérance; Enfant; Pompe à insuline; Diabète de type 1CSII, Continuous subcutaneous insulin infusion; IgE, Immunoglobulin E; NPH, Neutral protamine Ha
CSII and MDII for intensive diabetes management: Impact perceptions of older adult patients and their significant others
Keywords: Diabetes; CSII; MDII
Emerging diabetes therapies and technologies
Keywords: CSII; continuous subcutaneous insulin infusion; CGM; continuous glucose monitoring; DKA; diabetic ketoacidosis; DPP-IV; dipeptidyl peptidase-IV; EMEA; European Medicines Agency; FDA; Food and Drug Administration; FCL; fully closed-loop; GRAS; generally re
Is continuous glucose monitoring (CGM) for everyone?: To whom should CGM be prescribed and how?
Keywords: Type 1 diabetes; CGM; HbA1c, hypoglycaemia; CSII; Screening; Cost-efficiency ratio; Education; Prescription; Sensors; ReviewDiabète de type 1; MCG; HbA1c, hypoglycémies; Pompe à insuline; Sélection; Rapport cout-efficacité; Éducation; Prescription; Capteu
Emergent technologies applied to diabetes: What do we need to integrate continuous glucose monitoring into daily practice?: Where the long-term use of continuous glucose monitoring stands in 2011
Keywords: Type 1 diabetes; Continuous glucose monitoring; Intensive insulin regimen; CSII; Insulin pump; Therapeutic education; Interstitial glucose; ReviewDiabète de type 1; Mesure continue du glucose; Schéma basal bolus; Pompe à insuline; Éducation thérapeutique;
Deus ex machina: The use of technology in type 1 diabetes
Keywords: CSII; Insulin pump therapy; CGMS; Continuous glucose monitoring; Real time glucose monitoring; Closed loop system
Impact of dose adjustment for normal eating in Australia (OzDAFNE) on subjective wellbeing, coping resources and negative affects in adults with type 1 diabetes: A prospective comparison study
Keywords: CSII; continuous subcutaneous insulin infusion; MDI; multiple daily injections; OzDAFNE; Australian dose adjustment for normal eating; Type 1 diabetes; Structured patient education; Subjective wellbeing; Coping; Therapeutic alliance;
Development of a multi-parametric model predictive control algorithm for insulin delivery in type 1 diabetes mellitus using clinical parameters
Keywords: Biomedical control; Insulin delivery; Multi-parametric model predictive control; Type 1 diabetes mellitus; BG; blood glucose; CGM; continuous glucose monitoring; CF; correction factor; CHO; carbohydrate; CSII; continuous subcutaneous insulin infusion; FDA
Sexual activity in diabetic patients treated by continuous subcutaneous insulin infusion therapy
Keywords: Type 1 diabetes; CSII; HbA1c; Sexuality; Intercourse frequencyDiabète de type 1; Pompe à insuline; HbA1c; Sexualité
Analysis of continuous patient data from the Czech National Register of patients with type 1 and type 2 diabetes using insulin pump therapy
Keywords: Diabetes mellitus; Type I; Type II; CSII; Insulin pump
Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion ★
Keywords: CSII; Type 1 Diabetes; Pump infusion line; Glycemic control
Continuous subcutaneous insulin infusion (CSII) using an external insulin pump for the treatment of type 2 diabetes
Keywords: External insulin pump; CSII; Type 2 diabetes; Intensified insulin therapy; HbA1c; Diabetes; ReviewPompe externe; Diabète de type 2; Insulinothérapie intensifiée; HbA1c; Diabète; RevueCSII, continuous subcutaneous insulin infusion; MDI, multiple daily inje
Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection
Keywords: Type 1 Diabetes; CSII; Quality of life; RECPAM analysis;
Continuous glucose monitoring is a helpful tool for the modification and assessment of such a modified treatment of type 1 diabetes mellitus in children and adolescents
Keywords: continuous glucose monitoring; hypoglycemia; hyperglycemia; type 1 diabetes mellitus; HbA1c; ciÄ
gÅe monitorowanie glikemii; hipoglikemia; hiperglikemia; cukrzyca typu 1; HbA1c; T1DM; type 1 diabetes mellitus; CGM; continuous glucose monitoring; HbA1c; g
Insulin-pump use in everyday practice: Data from an exhaustive regional registry in France
Keywords: Diabetes; CSII; HbA1c; RegisterDiabète; Pompe à insuline; HbA1c; Registre
International survey of insulin pump users: Impact of continuous subcutaneous insulin infusion therapy on glucose control and quality of life
Keywords: Continuous subcutaneous insulin infusion; CSII; Insulin pump therapy; Metabolic control; Patient satisfaction
Nocturnal differences in subcutaneous tissue glucose between forearm and abdominal sites during continuous glucose monitoring in normal subjects
Keywords: Glucose sensors; Hypoglycaemia; Nocturnal; CSII; Senseurs de glucose; Hypoglycémie; Nocturne; Pompe à insuline;
Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy
Keywords: Type-1 diabetes; Basal; Insulin; Pump; CSII;
Tramadol enhances hepatic insulin sensitivity via enhancing insulin signaling cascade in the cerebral cortex and hypothalamus of 90% pancreatectomized rats
Keywords: Dexamethasone; Mu receptor agonist; Serotonin reuptake inhibitor; Cerebral cortex; Hypothalamus; Neuronal cells; CREB; cAMP response element binding protein; CSII; continuous subcutaneous insulin infusion therapy; DEX; dexamethasone; DMEM; Dulbecco's Modi